tiprankstipranks
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Compare Climb Bio (CLYM) vs. Competitors

694 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Climb Bio
$7.10
$339.15M
-4.53
528.32%
10 Buy
0 Hold
0 Sell
Strong Buy
Agenus
$4.20
$161.27M
811.87
147.06%
1 Buy
0 Hold
0 Sell
Moderate Buy
TuHURA Biosciences
$1.81
$115.08M
-1.21
-51.73%
2 Buy
0 Hold
0 Sell
Moderate Buy
Ovid Therapeutics
$2.60
$342.87M
-6.90
919.61%
8 Buy
0 Hold
0 Sell
Strong Buy
Cognition Therapeutics
$0.88
$78.65M
-8.98
175.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Tevogen Bio Holdings
$0.32
$24.19M
-2.09
-87.90%
0 Buy
1 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CLYM
Climb Bio
7.10
5.94
512.07%
AGEN
Agenus
4.20
2.58
159.26%
HURA
TuHURA Biosciences
1.81
-2.06
-53.23%
OVID
Ovid Therapeutics
2.60
2.35
919.61%
CGTX
Cognition Therapeutics
0.88
0.56
175.00%
TVGN
Tevogen Bio Holdings
5.81
-44.19
-88.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts